Business Wire

Visa, Circle and Haun Ventures Back Velocity in Series A Extension, Bringing Total Series A Funding to $48 million

15.9.2026 15:00:00 EEST | Business Wire | Press release

Share

Velocity, the stablecoin payments and treasury platform, today announced a $10 million extension to its Series A, with investment from Visa Ventures, Circle Ventures, Ripple, Haun Ventures, Translink Capital and Mirana Ventures. The extension follows Velocity’s $38 million Series A announced last month and will support the company’s work to bring stablecoin infrastructure to issuers, acquirers, payment providers, financial institutions and merchants worldwide.

“We are excited to welcome several new investors to Velocity, including Visa through Visa Ventures,” said Eric Queathem, founder and CEO of Velocity. “From day one, we have focused on improving how money moves through the payments ecosystem. These investors operate at the center of that ecosystem and will provide invaluable insight as we use stablecoins to transform the experience.”

Velocity is building infrastructure that enables institutions and businesses to use stablecoins for settlement, liquidity and treasury operations without replacing their existing systems. The platform is designed to make the movement of money behind payments more continuous, reduce reliance on prefunding and extend settlement beyond traditional banking hours.

“Stablecoins are playing an increasingly important role in reshaping how value moves across the Visa ecosystem, and companies like Velocity are helping accelerate adoption and unlock new opportunities for our customers and partners,” said Rubail Birwadker, Global Head of Growth Products and Strategic Partnerships at Visa. “We’re excited to invest in Eric and the Velocity team as they build the infrastructure needed to bring stablecoin-powered money movement to every business.”

The participation of Circle Ventures and Ripple brings Velocity together with two major companies advancing regulated stablecoins and their use in payments, liquidity and institutional finance. Translink Capital's investment adds a strategic bridge to Velocity's network of corporate and institutional partners across Asia. Their investment reflects a shared view that the next phase of stablecoin adoption will depend not only on the assets and blockchains themselves, but also on the infrastructure connecting them with the banking, treasury and settlement systems institutions already use.

Haun Ventures brings a long-term perspective shaped by investments across multiple generations of stablecoin and financial infrastructure companies. Its investment in Velocity reflects its conviction that stablecoins will become increasingly embedded in the systems underpinning payments, banking and treasury.

“Haun Ventures had early conviction in stablecoin infrastructure, with investments in both Bridge and BVNK. Velocity represents the next evolution of that thesis,” said Chris Ahn, Partner at Haun Ventures. “Stablecoins are moving beyond faster transactions to become a foundational layer for global finance. Velocity is building the technology that enables major institutions to embed them directly into their payment and treasury operations.”

With total Series A funding of $48 million, Velocity will continue to expand its platform and deepen its work across the global payments and treasury ecosystem. The company aims to make stablecoins a seamless part of how institutions move and manage money; connecting issuers, acquirers, merchants and financial institutions through infrastructure designed for continuous global settlement.

About Velocity

Velocity is the first stablecoin payments and treasury platform purpose-built for global CFOs and Treasurers. By combining regulated stablecoins with traditional financial infrastructure, the platform enables companies to move funds in real time, manage liquidity more efficiently, and simplify global settlement. Velocity helps finance teams reduce FX and liquidity friction, unlock trapped capital, and gain greater visibility into global cash flows.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260915301952/en/

Contacts

press@velocity.xyz

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye